GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanosphere Health Sciences Inc (OTCPK:NSHSF) » Definitions » Shiller PE Ratio

Nanosphere Health Sciences (Nanosphere Health Sciences) Shiller PE Ratio : (As of May. 23, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Nanosphere Health Sciences Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Nanosphere Health Sciences Shiller PE Ratio Historical Data

The historical data trend for Nanosphere Health Sciences's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanosphere Health Sciences Shiller PE Ratio Chart

Nanosphere Health Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Nanosphere Health Sciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Nanosphere Health Sciences's Shiller PE Ratio

For the Biotechnology subindustry, Nanosphere Health Sciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanosphere Health Sciences's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanosphere Health Sciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Nanosphere Health Sciences's Shiller PE Ratio falls into.



Nanosphere Health Sciences Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Nanosphere Health Sciences's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Nanosphere Health Sciences's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0/125.0724*125.0724
=0.000

Current CPI (Dec. 2023) = 125.0724.

Nanosphere Health Sciences Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -1.086 98.604 -1.378
201406 -0.750 99.473 -0.943
201409 -0.179 99.394 -0.225
201412 -0.116 98.367 -0.147
201503 -0.158 99.789 -0.198
201506 -0.077 100.500 -0.096
201509 -0.050 100.421 -0.062
201512 -0.139 99.947 -0.174
201603 -0.154 101.054 -0.191
201606 -0.155 102.002 -0.190
201609 -0.608 101.765 -0.747
201612 0.012 101.449 0.015
201703 -0.182 102.634 -0.222
201706 -0.127 103.029 -0.154
201709 -0.210 103.345 -0.254
201712 -1.933 103.345 -2.339
201803 -0.200 105.004 -0.238
201806 -0.400 105.557 -0.474
201809 -0.200 105.636 -0.237
201812 -0.400 105.399 -0.475
201903 -0.200 106.979 -0.234
201906 -0.200 107.690 -0.232
201909 -0.200 107.611 -0.232
201912 -0.200 107.769 -0.232
202003 -0.043 107.927 -0.050
202006 -0.020 108.401 -0.023
202009 -0.010 108.164 -0.012
202012 -0.030 108.559 -0.035
202103 -0.012 110.298 -0.014
202106 -0.020 111.720 -0.022
202109 -0.060 112.905 -0.066
202112 0.018 113.774 0.020
202203 -0.007 117.646 -0.007
202206 -0.010 120.806 -0.010
202209 -0.003 120.648 -0.003
202212 -0.020 120.964 -0.021
202303 -0.010 122.702 -0.010
202306 -0.010 124.203 -0.010
202309 -0.004 125.230 -0.004
202312 0.000 125.072 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Nanosphere Health Sciences  (OTCPK:NSHSF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Nanosphere Health Sciences Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Nanosphere Health Sciences's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanosphere Health Sciences (Nanosphere Health Sciences) Business Description

Traded in Other Exchanges
Address
1090 West Georgia Street, Suite 488, Vancouver, BC, CAN, V6E 3V7
Nanosphere Health Sciences Inc is a nano-biotechnology company. The company is focused on providing next-generation delivery of nutritive elements and medications. Its NanoSphere Delivery System platform technology addresses the problems of low bioavailability and excessive dosage amounts of a wide range of bioactive compounds. It focuses on developing nanoencapsulation technology for the delivery of nutritive elements and medicants through licensing arrangements.